Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia.
Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Cancer. 2011 Jan 15; 117(2):327-35.